Finding new & better treatments for Type 1 Diabetes

Type 1 Diabetes UK Immunotherapy Consortium

USTEKID

Trial of a new medication in people with Type 1 diabetes aged 12-18 and within 100 days of diagnosis

Find out more

Immunotherapy Treatment for Type 1 Diabetes

Colin Dayan explains immunotherapy for T1D

Find out more

Finding new & better treatments for Type 1 Diabetes

Type 1 Diabetes UK Immunotherapy Consortium

Trial of a new medication in people with Type 1 diabetes aged 12-18 and within 100 days of diagnosis.

USTEKID Trial Open To Recruitment

Find out more
Find Out More

Colin Dayan explains immunotherapy for T1D – here interviewed by Vivienne Parry OBE prior to a plenary lecture at the EASD in Berlin Sept 2018.

Immunotherapy Treatment for Type 1 Diabetes

Join Our Research and Help Change the Future of Type 1 Diabetes

If you or your family want to find out more about taking part in a clinical trial, please click

1
2
3
4
5
6
7
8
9
10
11
12
13

23 Research Centres

We have a network of 23 Research Sites throughout the UK that will be conducting T1D Immunotherapy trials, with additional referrals to those sites from the ADDRESS-2 recruitment support network.

Type 1 Diabetes UK Immunotherapy Consortium

Finding new & better treatments for Type 1 Diabetes

Type 1 Diabetes UK Immunotherapy Consortium (T1D UK) was set up in 2015 with major funding from Diabetes UK & the JDRF, to promote, develop and support immunotherapy research in T1D.

Find out more

Our Partners

The consortium is funded by DUK and JDRF with a network of partners.

 
 

Diabetes research would not be possible without the support of people with diabetes.